Brief by Shorts91 Newsdesk / 03:36pm on 13 Mar 2025,Thursday International
Donald Trump's planned tariffs on Indian pharmaceuticals may raise drug costs for millions of Americans. India supplies nearly 50% of the US's generic drugs, saving $219B in 2022. Experts warn tariffs could worsen drug shortages, especially for hypertension and mental health medications. Indian firms, already operating on thin margins, may struggle with higher costs. Commerce Minister Piyush Goyal recently visited the US to negotiate a deal. Trump claims India will cut tariffs, but no official confirmation has been given. Industry leaders caution that relocation to the US would be costly and take years.
